Pregabalin Capsule
Product Images NDC 58118-1462

Product Visual Gallery

This gallery contains 15 technical images submitted to the FDA as part of the official labeling for Pregabalin (NDC 58118-1462). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Clinical Solutions Wholesale, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Pregabalin 25mg Capsule 30ct Blister Card (Prega 25mg 90s A)

FDA Label Image

Pregabalin-equation (Pregabalin Equation)

This text provides information on a formula for estimating creatinine clearance (CLCr) using the patient's age, weight, and serum creatinine level. The formula is specific to female patients with a correction factor of greater than 0.85.*

FDA Label Image

Pregabalin-fig-a (Pregabalin Fig A)

This text provides information about the responder rate in percentage, along with dosages of placebo and different quantities of a substance measured in milligrams per kilogram per day. The text also mentions a value of 201% for the responder rate.*

FDA Label Image

Pregabalin-figure-6 (Pregabalin Figure 6)

This text contains information about different studies (Study E1, Study E3) comparing various doses of a medication (ranging from 50mg/day to 600mg/day) against a placebo. The results indicate percentage changes in certain parameters and suggest that the higher doses may have a statistically significant impact compared to the placebo.*

FDA Label Image

Pregabalin-figure-7 (Pregabalin Figure 7)

FDA Label Image

Study Dpn 1 (Pregabalin Image 1)

FDA Label Image

Study Sci 1 (Pregabalin Image 10)

FDA Label Image

Pain Intensity-study Sci 2 (Pregabalin Image 11)

FDA Label Image

Study Dpn 2 (Pregabalin Image 2)

FDA Label Image

Study Phn 1 (Pregabalin Image 3)

FDA Label Image

Study Phn 2 (Pregabalin Image 4)

This text mentions the improvement in patients after taking Pregabalin at different doses. It also refers to placebo and mentions the percentage of improvement in pain from the baseline.*

FDA Label Image

Study Phn 3 (Pregabalin Image 5)

This text appears to show data related to patient improvement with different treatments and pain levels. It mentions the number of patients improved, the use of Pregatalin medication at different doses, and a placebo. The data might also include the percentage of improvement in pain from the baseline.*

FDA Label Image

Fibromyalgia Study F1 (Pregabalin Image 8)

This text provides information about the percentage of patients who have shown improvement in pain after being administered different doses of Pregabalin. The table displays the percentage of improvement from baseline for each dose: 100 mg, 450 mg, and 300 mg. For instance, patients showed a 20% improvement when taking a 450 mg daily dose of Pregabalin.*

FDA Label Image

Fibromyalgia Study F2 (Pregabalin Image 9)

FDA Label Image

Pregabalin Structure (Pregabalin Srtuc 1)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.